BIIB
FLIXABI®, Biogen’s Infliximab Biosimilar Referencing Remicade®, Approved in the European Union
Monday, May 30, 2016 1 min read
Key Takeaway: FLIXABI®, Biogen’s Infliximab Biosimilar Referencing Remicade®, Approved in the European Union
Full Press Release Details
FLIXABI®, Biogen’s Infliximab Biosimilar Referencing Remicade®, Approved in the European Union.